October 10, 2016 BORDEAUX, France & BOSTON–(BUSINESS WIRE) IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today announces its sales for the third quarter and first nine months to September 30, 2016. Ludovic Lastennet, CEO of Implanet, says: “This was the Company’s second most […]